Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer
Autor: | Secord, Angeles Alvarez, McCollum, Michael, Davidson, Brittany A., Broadwater, Gloria, Squatrito, Robert, Havrilesky, Laura J., Gabel, Anne C., Starr, Mark D., Brady, J. Chris, Nixon, Andrew B., Duska, Linda R. |
---|---|
Zdroj: | In Gynecologic Oncology June 2019 153(3):555-561 |
Databáze: | ScienceDirect |
Externí odkaz: |